Literature DB >> 25902333

Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer.

Jen-Yang Tang, Ruei-Nian Li, Ping-Ho Chen, Hurng-Wern Huang, Ming-Feng Hou, Hsueh-Wei Chang1.   

Abstract

Radiotherapy effectively destroys cancer cells in many sites of the body, but several limitations remain. This study investigated alternative splicing, which is a common mechanism of increased diversity in mRNAs and proteins. The relationships of alternative splicing to DNA damage and radiation such as UV and ionizing radiation were analyzed. The DNA damage responses of many genes involved in alternative splicing were compared between non-radiation and radiation treatments. Drugs that affect radioresistence or radiosensitization by modulating the effects of alternative splicing and radiation were also reviewed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25902333     DOI: 10.2174/1871520615666150422145005

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

1.  Molecularly targeted radiosensitization chances towards gene aberration-due organ confined/regionally advanced prostate cancer radioresistance.

Authors:  C Alberti
Journal:  G Chir       Date:  2015 May-Jun

Review 2.  Cancer metabolism and intervention therapy.

Authors:  Huakan Zhao; Yongsheng Li
Journal:  Mol Biomed       Date:  2021-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.